Find information on thousands of medical conditions and prescription drugs.

Cladribine

Cladribine is a drug used to treat hairy cell leukemia (leukemic reticuloendotheliosis). It is a synthetic antineoplastic agent with immunosuppressive effects. Its use in multiple sclerosis is being studied.

A

B

C

Calcium folinate

Chenodeoxycholic acid

Chloramphenicol

Chlordiazepoxide

Chlorprothixene

Chlortetracycline

Choriogonadotropin alfa

Chorionic gonadotropin

Clavulanic acid

Cyclobenzaprine

Cyclophosphamide

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Gale Encyclopedia of Cancer : Cladribine $3.10


	Leukemia cutis is a B-cell tumor of the skin and is uncommon - Washington Whispers - Brief Article LEUKEMIA CUTIS IS A B-CELL TUMOR OF THE SKIN and is uncommon. This case report shows the successful use of the chemotherapeutic agent cladribine in the treatment of leukemia culls. After four cours From Journal of Drugs in Dermatology, 1/1/03

	Traitorous lymphocytes; drug assaults diseases from leukemia to MS - cladribine; multiple sclerosis - Cover Story Cladribine is effectively used for treating people with hairy-cell leukemia, but the compound also seems to slow the progress of several other autoimmune ... From Science News, 6/11/94 by Kathy A. Fackelmann

	Cladribine Definition Cladribine, also known by the brand name Leustatin, is a chemotherapy medicine used to treat certain types of cancer by destroying ... From Gale Encyclopedia of Cancer, by RPh. Nancy J. Beaulieu, BCOP

	Primary pulmonary hypertension in a patient with CD8/T-cell large granulocyte leukemia: amelioration by cladribine therapy We report a case of primary pulmonary hypertension in an adult man with CD8/T-cell large granulocyte leukemia. Successful treatment of his leukemia ... From CHEST, 8/1/97 by Leonard J. Rossoff

	Cladribine in the treatment of progressive multiple sclerosis - adapted from the Lancet, July 2, 1994 - Tips from Other Journals Because autoimmune mechanisms have been implicated in the etiology of multiple sclerosis, antilymphocytic agents that were originally developed to treat ... From American Family Physician, 1/1/95

	Thalidomode as a potential treatment for scleromyxedema Caradonna S, Jacobe H. Arch Dermatol 2004 Mar; 140(3):277-80. The authors present a case of a 39-year-old female with a history of scleromyxedema for about one year. The patient's only complaint From Journal of Drugs in Dermatology, 7/1/04

	Serono and IVAX Announce Positive Outcome of Pharmacokinetic Trials with Oral Cladribine Business Editors/Health/Medical Writers GENEVA & MIAMI--(BUSINESS WIRE)--March 23, 2004 Cladribine Targeted to Become First Oral Therapy for Multiple ... From Business Wire, 3/23/04

	Therapeutic gains RealLiving with Multiple Sclerosis New treatment guidelines outline diseasemodifying MS pharmacotherapy options. FOR YEARS, ORGANIZATIONS such as the National Multiple Sclerosis Society have reco From Real Living with Multiple Sclerosis, 4/1/02 by Pizzi, D M

Home

Contact

Resources

ebay